Literature DB >> 18686973

Development of a countergradient parking system for gradient liquid chromatography with online biochemical detection of serine protease inhibitors.

Nils Helge Schebb1, Ferry Heus, Thorsten Saenger, Uwe Karst, Hubertus Irth, Jeroen Kool.   

Abstract

A gradient HPLC approach in combination with a countergradient system for online biochemical detection (BCD) to screen for inhibitors of serine proteases is described. For gradient separations, this novel countergradient system was developed to produce a biocompatible constant solvent composition in the BCD. The countergradient system is based on retaining complete gradients in an additional preparative HPLC column, followed by subsequent and reversible elution to the separation column effluent. Major advantages compared with existing countergradient systems are that no additional LC pumps are needed and enhanced stability. The developed countergradient system was systematically characterized applying different gradient programs. Inhibitors eluting in a postcolumn continuous flow analysis interfere with the enzymatic release of fluorescent 7-amino-4-methylcoumarin (AMC) from an AMC-labeled peptide. The inhibitory activity of eluting substances is sensitively detected as the degree of reduced fluorescence intensity. This biochemical detection system (BCD) for proteases was validated with three known inhibitors of the benzamidine type. Their IC 50 values were in good accordance with the results of conventional plate reader assays. Finally, a small library of protease inhibitors was successfully screened with the combination of the BCD and the countergradient system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18686973     DOI: 10.1021/ac801035e

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  7 in total

1.  Development of an online p38α mitogen-activated protein kinase binding assay and integration of LC-HR-MS.

Authors:  David Falck; Jon S B de Vlieger; Wilfried M A Niessen; Jeroen Kool; Maarten Honing; Martin Giera; Hubertus Irth
Journal:  Anal Bioanal Chem       Date:  2010-08-22       Impact factor: 4.142

2.  Development of On-line Liquid Chromatography-Biochemical Detection for Soluble Epoxide Hydrolase Inhibitors in Mixtures.

Authors:  David Falck; Nils Helge Schebb; Setyo Prihatiningtyas; Jiawen Zhang; Ferry Heus; Christophe Morisseau; Jeroen Kool; Bruce D Hammock; Wilfried M A Niessen
Journal:  Chromatographia       Date:  2012-11-07       Impact factor: 2.044

3.  A unifying review of bioassay-guided fractionation, effect-directed analysis and related techniques.

Authors:  Michael G Weller
Journal:  Sensors (Basel)       Date:  2012-07-04       Impact factor: 3.576

4.  Development of a microfluidic confocal fluorescence detection system for the hyphenation of nano-LC to on-line biochemical assays.

Authors:  Ferry Heus; Martin Giera; Gerdien E de Kloe; Dick van Iperen; Joost Buijs; Tariq T Nahar; August B Smit; Henk Lingeman; Iwan J P de Esch; Wilfried M A Niessen; Hubertus Irth; Jeroen Kool
Journal:  Anal Bioanal Chem       Date:  2010-09-25       Impact factor: 4.142

Review 5.  Advances in mass spectrometry-based post-column bioaffinity profiling of mixtures.

Authors:  Jeroen Kool; Martin Giera; Hubertus Irth; Wilfried M A Niessen
Journal:  Anal Bioanal Chem       Date:  2010-11-24       Impact factor: 4.142

Review 6.  Development of on-line high performance liquid chromatography (HPLC)-biochemical detection methods as tools in the identification of bioactives.

Authors:  Christiaan J Malherbe; Dalene De Beer; Elizabeth Joubert
Journal:  Int J Mol Sci       Date:  2012-03-07       Impact factor: 6.208

7.  Development of Plate Reader and On-Line Microfluidic Screening to Identify Ligands of the 5-Hydroxytryptamine Binding Protein in Venoms.

Authors:  Reka A Otvos; Janaki Krishnamoorthy Iyer; René van Elk; Chris Ulens; Wilfried M A Niessen; Govert W Somsen; R Manjunatha Kini; August B Smit; Jeroen Kool
Journal:  Toxins (Basel)       Date:  2015-06-24       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.